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Introduction: Allostatic load (AL) refers to the physiological response associated with
the burden of chronic stress. Excessive weight is an important source of physiological
stress that promotes a detrimental chronic low-inflammation state. In order to define
a correlation between cumulative biological dysregulation and excess weight, we
measured AL scores in a pediatric population.
Patients and Methods: We enrolled 164 children and adolescents (11.89 ± 3.89).
According to their body mass index (BMI) threshold, subjects were classified as normal
in the BMI < 75th percentile, overweight in the BMI 75–95th percentile or obese in
the BMI >95th percentile. Data based on 16 biomarkers were used to create the AL
score. A dichotomous outcome for high AL was defined in those who had more than
four dysregulated components.
Results: High AL was noted in 88/164 subjects (53.65%), without significant differences
between genders (p = 0.07) or pubertal status (p = 0.10). Subjects with a high AL, in
addition to a higher BMI (p < 0.001), showed higher WC and WC/HtR (p < 0.001),
triglycerides (p = 0.002), fasting blood glucose (p = 0.03), insulin resistance (p < 0.001),
systolic (p < 0.001) and diastolic blood pressure (p = 0.001), GGT (p = 0.01), PCR (p
= 0.01), and calprotectin (p < 0.01) as well as lower HDL cholesterol (p = 0.002) than
subjects with a low AL. The rate of the cumulative biological dysregulation increased
progressively with increases in BMI (p < 0.001).
Conclusions: A high AL was associated with excess weight. AL may be
considered a significant factor correlated with increased morbidity in children who
are overweight/obese.
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INTRODUCTION
Stress is a complex process involving individual resources,
vulnerabilities as well as the environment (1). Psychological,
behavioral and physiological adaptations to survival
requirements are necessary for an individual’s capacity to
adapt (2–4). Chronic exposure to stressful stimuli, is referred
to as allostatic load (AL), and results in “wear and tear” of the
adaptive regulatory systems resulting in biological alterations
that weaken stress adaptive processes and increase disease
susceptibility (2, 3). Chronic dietary imbalances, for example as
observed in western diets rich in fats and refined sugars that lead
to excessive weight gain, may affect physiological performance
promoting chronic low-inflammation that is detrimental for
both the physical and mental status (5–7). The consequential
increase in pro-inflammatory cytokines, such as IL-6, leads to
increased hypothalamic-pituitary-adrenal (HPA-) axis activity
(8) and promotes chronic stress. In this study, we measured AL
scores in a Caucasian pediatric population, in order to define
a correlation between cumulative biological dysregulation and
excess weight.
PATIENTS AND METHODS
Patients
We consecutively enrolled 164 Caucasian children and
adolescents (79 females and 85 males) aged 11.89 ± 3.89 y
(range 2.6–18.0 y). The subjects were referred to our institution
for auxological evaluation or obesity by their general practitioner
or by their primary care pediatric consultant, between October
2017 and March 2018.
After receiving information on the nature of the study,
written informed consent was obtained from the parents of the
patients or the participants. Participants were excluded from
the study if they had concurrent chronic or acute illnesses, any
known secondary syndromes with or without obesity, or were on
any medications. According to body mass index (BMI) cutoffs
and age-sex percentiles (9) subjects were classified as normal
for weight: BMI < 75th percentile, overweight: BMI 75–95th
percentile or obese: BMI >95th percentile.
Methods
Allostatic Load Definition
We used 16 biomarkers to create an AL summary score.
In the original definition of the AL index, (2) biomarkers
of cardiovascular, metabolic, and endocrine stress regulatory
systems were included. Acknowledging the important role that
inflammation plays in the response to stress and many diseases,
inflammation biomarkers were added at a later time (3). As
previously reported (10), since the AL biomarker panel is
not univocal (11), we included markers for cardiovascular,
metabolic, inflammatory and stress hormone status (11). As
markers of cardiovascular and metabolic activity, in addition
to BMI, we included parameters that are usually considered
in metabolic syndromes, such as, waist circumference (WC),
waist to height ratio (WHtR), blood pressure, fasting lipid
and blood glucose levels, insulin resistance, transaminases and
homocysteine levels. The latter is recognized as an independent
risk factor for cardiovascular disease (12). As inflammatory
markers we included calprotectin (13), IL-6 and PCR; while the
serum cortisol level was measured as a marker of stress.
As previously described (10) for each biomarker, a
dichotomous variable was constructed in which 0 and 1,
respectively, correlated with values under the clinical cutoffs
for age and gender and those in the pathological clinical range.
Risk factors were summed to calculate a total AL score and the
population median for the sum of the dysregulated components
in our sample was 4. All patients who scored <4 were considered
low AL and vice versa for all the others. As previously mentioned
(10) we used this dichotomous scoring system to achieve a
well-matched sample size and consequently obtained more
statistical power.
Auxological Parameter Evaluation
In all patients, weight, height, waist circumference (WC),
pubertal stage according to Marshall and Tanner (14, 15) and
blood pressure were measured. BMI and the waist-to-height
ratio (W/HtR) were also calculated. Weight, height, BMI, waist
circumference and blood pressure were measured as previously
reported (13). A BMI cut-off above the 75th percentile, indicative
of an overweight status or obesity, was considered pathological;
WC was considered pathological when >95th percentile for age
and sex (16). Abdominal obesity was defined with a W/HtR >0.5
(17). Hypertension was defined for SBP or DBP as equal to or
above the 95th percentile for age and sex (18).
Metabolic, Hormonal, and Inflammatory Parameters
Metabolic and hormonal parameters included fasting blood
glucose (FBG), total cholesterol, high-density lipoprotein (HDL)
cholesterol; triglycerides (TG), aspartate aminotransferase
(AST), alanine aminotransferase (ALT), gamma-glutamyl-
transferase (GGT), homocysteine, insulin and cortisol levels.
The formula: insulin resistance = (fasting plasma insulin in
mUI/L × fasting plasma glucose in mmol/L/22.5) was used
to calculate the homeostasis model assessment for insulin
resistance (HOMA-IR).
Elevated FBG was defined with values exceeding 100 mg/dl
and impaired insulin sensitivity (ISI) with an HOMA-IR
exceeding the 97.5th percentile for age and sex (19). Lipid fasting
levels were considered pathological for total-cholesterol (TC) and
TG values >95th percentile and an HDL cholesterol level <5th
percentile for age and sex (20). Pathological ALT (normal value
11–39 mU/ml) and AST (normal value 11–34 mU/ml) and/or
GGT (normal value 11–53 mU/ml) levels identified subjects with
abnormal hepatic function.
Fasting blood glucose, insulin, total cholesterol, HDL, TG,
AST, ALT, GGT, and PCR were measured with clinical chemistry
methods using the Advia XPT (Siemens Healthcare). Morning
serum cortisol was measured using the chemiluminescent
enzyme immunoassay Immulite (Siemens Healthcare; intra-
and inter-assay precision were 5.2 and 6.1%, respectively).
Plasma homocysteine levels were measured with a competitive
immunoassay using direct, chemiluminescent technology (Advia
Centaur, Siemens Healthcare; intra- and inter-assay precision
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were 3.7 and 4.7%, respectively). Serum IL-6 was titered
using an enzyme-linked immunosorbent assay kit (R and D
Systems Minneapolis; range 0–12.5 pg/ml; intra- and inter-assay
precision were 2.6 and 4.5%, respectively). Serum calprotectin
was measured with a commercial ELISA assay (intra- and inter-
assay precision were 8.0 and 9.0%, respectively) as previously
described (13).
Statistical Analysis
The Shapiro-Wilk test was used to determine normal
distributions of quantitative variables and the results are reported
as the mean and standard deviation (SD). Gender and pubertal
stages were considered as qualitative variables and summarized
as counts and percentages and compared between groups
with the chi-square test. Associations between dichotomous
AL (high vs. low) and clinical, metabolic and hormonal data
were evaluated by the Student t-test for independent samples.
The non-parametric test for trends across ordered groups was
used to assess the effect of obesity on cumulative biological
dysregulation. All tests were two-sided and a p-value < 0.05 was
considered statistically significant. The STATA statistical package
was used to perform data analyses (release 15 January 2017, Stata
Corporation, College Station, Texas, USA).
RESULTS
Based on the BMI percentile threshold, 49 of the 164 (29.88%)
enrolled patients were normal for weight and 115 (70.12%)
were overweight or obese. Tables 1, 2 show the biomarker
distributions utilized for the AL summary score, and the number
of dysregulated values used to generate the score.
A high AL score was observed in 88/164 subjects (53.65%),
without significant differences between genders (p = 0.07) or
pubertal status (p = 0.10). In Table 3, we report the correlations
between AL, clinical data and metabolic/hormonal parameters.
Subjects with a significantly higher BMI (p < 0.001), WC and
WC/HtR (p < 0.001), triglycerides (p = 0.002), fasting blood
glucose (p= 0.03), GGT (p= 0.01), PCR (p= 0.01), calprotectin
(p < 0.01) insulin resistance (p < 0.001), systolic (p < 0.0019),
and diastolic blood pressure (p = 0.001) values as well as lower
HDL cholesterol (p= 0.002) levels had a higher AL score.
A significant correlation between high AL score and excess
weight was observed (87/88 of patients with pathological BMI
had a high AL score vs. 1/49 in normal weight subjects p< 0.001).
It was also noted that an increasing BMI correlated with increased
cumulative biological dysregulation (p < 0.001).
DISCUSSION
In our pediatric population, we observed a significant correlation
between high AL and overweight/obesity status and an
altered cardio-metabolic profile. The cumulative biological
dysregulation rose in the higher BMI categories. AL may
be considered a significant factor correlated with increased
morbidity in overweight/obese children.
Cumulative biological system dysregulation has been closely
linked to AL (21) and has been shown to be associated with a poor
TABLE 1 | Parameter distributions used to create the allostatic load (AL) summary
score.
Parameters Absent Present
Body mass index > 75th percentile 49 (29.88%) 115 (70.12%)
Waist circumference > 95th
percentile
57 (34.76%) 107(65.24%)
Waist to height ratio > 0.5 68 (41.46%) 96 (58.54%)
Systolic blood pressure ≥ 95th
percentile
144 (87.8%) 20 (12.2%)
Diastolic blood pressure > 95th
percentile
153 (93.29%) 11 (6.71%)
High density lipoprotein (HDL)
cholesterol < 5th percentile
113 (81.09%) 31 (18.91%)
Total cholesterol > 95th percentile 149 (90.85%) 15 (9.15%)
Triglycerides > 95th percentile 152 (92.68%) 12 (7.32%)
Fasting blood glucose > 100 mg/dl 161 (98.17%) 3 (1.83%)
HOMA-IR > 95th percentile 136 (82.92) 28 (17.18%)
Pathological ALT (nv 11–39 mU/ml)
and AST (nv 11–34 mU/ml) and/or
GGT (nv 11–53 mU/ml)
162 (98.78%) 2 (1.22%)
Homocysteine (nv 5–13.9 µmol /L) 132 (80.48%) 32 (19.52%)
PCR > 0.5 mg/L 145 (88.41%) 19 (11.59%)
Pathological IL-6 (nv 0–12.5 pg/ml) 160 (97.56%) 4 (2.44%)
Pathological calprotectin (nv
0.3–1.6µg/ml)
75 (45.73%) 89 (54.27%)
Elevated morning cortisol level (nv
4.3–22.4 µg /ml)
163 (99.39%) 1 (0.61%)
nv, normal value; HOMA-IR, homeostasis model assessment for insulin resistance.
TABLE 2 | Number of dysregulated components used to create the allostatic load
summary score.
Number of AL
parameters
Percentage of
patients (%)
Cumulative percentage
of patients (%)
0 14.02 14.02
1 12.80 26.83
2 4.27 31.10
3 15.24 46.34
4 15.24 61.59
5 17.68 79.27
6 11.59 90.85
7 5.49 96.34
8 1.22 97.56
9 1.83 99.39
10 0.61 100
health status, thus representing a key physiological impairment
factor in the prodromal stages of disease (22). We detected
a correlation between high AL and overlapping metabolic
syndrome (MetS) parameters, such as abdominal obesity,
high triglyceride levels, insulin resistance and hypertension,
confirming our previous results showing a significant MetS
increase with increased obesity severity in children (23).
Therefore, these results suggest that AL may forecast important
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TABLE 3 | Correlation between allostatic load (AL), clinical data, and
biochemical/hormonal parameters.
Parameters Low AL (<4) High AL (≥4) p_value
Height (cm) 146.59 ± 22.82 150.58 ± 15.47 0.18
Weight (Kg) 45.22 ± 17.02 59.92 ± 17.65 <0.001
Body Mass Index (kg/m2) 21.23 ± 11.88 25.8 ± 3.88 <0.001
Waist circumference (cm) 72.47 ± 10.78 84.98 ± 9.71 <0.001
Waist to height ratio > 0.5 0.34 ± 0.04 0.55 ± 0.52 <0.001
Pubertal status*
Tanner stage 1 30 (39.47) 25 (28.41) 0.10
Tanner stages 2–3 40 (52.63) 55 (62.50)
Tanner stages 4–5 6 (7.80) 8 (9.09)
Systolic blood pressure
(mmHg)
106.54 ± 9.84 112.82 ± 10.15 <0.001
Diastolic blood pressure
(mmHg)
66.53 ± 8.26 70.57 ± 8.04 0.001
High density lipoprotein
cholesterol (mg/dL)
55.73 ± 11.32 49.61 ± 11.02 0.002
Total cholesterol (mg/dL) 152.87 ± 22.95 160.17 ± 29.55 0.14
Triglycerides (mg/dL) 60.04 ± 29.2 80.98 ± 41.8 0.002
Fasting blood glucose
(mg/dL)
72.89 ± 10.57 76.71 ± 2.04 0.03
HOMA-IR 1.46 ± 1.13 2.57 ± 1.96 <0.001
Aspartate Aminotransferase
(mU/ml)
23.08 ± 5.45 23.33 ± 13.26 0.9
Alanine Aminotransferase
(mU/ml)
14.84 ± 5.36 17.56 ± 9.16 0.06
Gamma-Glutamyl
Transferase (mU/ml)
11.83 ± 4.64 14.58 ± 6.34 0.01
Homocysteine (µmol /L) 12.68 ± 7.52 13.11 ± 3.14 0.67
PCR (mg/L)** 0.04 (0.02–0.1) 0.16 (0.03–0.48) 0.01
IL-6 (pg/ml)** 1.97 (0.8–5.7) 2.83 (1.51–5.77) 0.23
Calprotectin (µg/ml)** 1.1 (0.8–1.9) 2.6 (1.7–4.3) <0.001
Cortisol (µg/ml) 8.20 ± 3.97 8.85 ± 4.89 0.5
AL, allostatic load. *Data are expressed as the number of patients (percentage). **Data
are expressed as the median (interquartile range).
clinical consequences including cardiovascular events and
metabolic disease, as well as increased mortality (2, 3).
In the children and adolescents, high AL scores correlated
with excess weight and increases in the BMI categories. As
reported by Foss et al. (8), obesity represents a disruption of
homeostasis and may be considered a potential physiological
stress inducer. While it seems evident that stress induces obesity,
the reverse is not well-documented. Our data support that this
hypothesis should be seriously considered at the pediatric age,
where stress experience is limited compared to data reported on
adults. Chronic low-grade activation of the inflammatory system
is a common feature of obesity and is associated with increased
secretion of pro-inflammatory cytokine, such as IL-1, IL-6 and
tumor necrosis factor, that trigger stimulation of HPA axis by the
adipocytes, thereby increasing cortisol release in order to limit
the inflammation reaction (24).
Another feature of obesity is increased leptin secretion (25, 26)
that appears to be functionally connected with the HPA axis in
humans (27, 28). Hyperleptinemia, which is commonly observed
in obesity, can also play a role in the stress reaction.
In our population, we also detected a correlation between high
AL and calprotectin levels, which has previously been associated
with obesity-related chronic low-grade inflammation in children
(13). The role of this molecule on the risk of developing comorbid
inflammatory conditions, should be considered.
Finally, food quality and the amount of energy consumed
in relation to daily recommended requirements are key
determinants of the effects that contribute to chronic disease.
Dietary patterns have been associated with higher AL scores (29),
indicating the negative impact of refined and simple sugars as
well as saturated and trans fatty acids in long term causes of
chronic degenerative diseases (30, 31).
We acknowledge that the study has humble limitations
starting from the relatively small sample size, which could
have limited the analysis. Therefore, future studies with
larger cohorts are mandatory. Additionally, even though our
observational study revealed a higher cumulative biological
dysregulation in patients with excessive weight increases, this
does not prove causality and it is difficult to determine
whether AL is a cause or consequence of obesity. In this
pediatric population, longitudinal studies would be useful
to define the impact of cumulative biological dysregulation
on health. Finally, we evaluated a cohort of children in
which several stressors may have simultaneously affected
AL scores, including unhealthy lifestyle, chronic low-grade
inflammation and hormonal dysregulation. Further research
aimed at single stress parameter analysis is necessary to
confirm the relationships between excess weight and cumulative
biological dysregulation.
In conclusion, we describe a correlation between cumulative
biological dysregulation and excess weight in children and
adolescents, suggesting that AL could be a useful index of health
risk in the pediatric population offering a valuable measure
to predict complications in obese children and promote early
tailored interventions to enhance their quality of life.
DATA AVAILABILITY
The raw data supporting the conclusions of this manuscript will
be made available by the authors, without undue reservation, to
any qualified researcher.
ETHICS STATEMENT
This study was approved by the Institutional Review Board of
the Fondazione IRCCS Policlinico San Matteo, Pavia (Protocol
number: 20150005231). After receiving information on the
nature of the study, written informed consent was obtained from
the patients’ parents or the patients themselves.
AUTHOR CONTRIBUTIONS
VC, DL, and HC designed the experiments, provided patient
samples, wrote, and supervised the manuscript. GP wrote and
Frontiers in Pediatrics | www.frontiersin.org 4 August 2019 | Volume 7 | Article 335
Calcaterra et al. Allostatic Load in Obese Children
supervised the manuscript. FV, GC, CR, and CM designed
the experiments and provided the patient samples. AdS
performed the statistical analysis. MD and RA performed the
biochemical analysis. All authors approved the final version of
the manuscript.
ACKNOWLEDGMENTS
We thank Dr. L. Kelly for English revision of the
manuscript and Dr. C. Torre for technical support in the
immunoassay evaluation.
REFERENCES
1. Ottino-González J, Jurado MA, García-García I, Segura B, Marqués-Iturria
I, Sender-Palacios MJ, et al. Allostatic load is linked to cortical thickness
changes depending on body-weight status. Front Hum Neurosci. (2017)
11:639. doi: 10.3389/fnhum.2017.00639
2. Seeman M, Stein Merkin S, Karlamangla A, Koretz B, Seeman T. Social status
and biological dysregulation: the “status syndrome” and allostatic load. Soc Sci
Med. (2014) 118:143–51. doi: 10.1016/j.socscimed.2014.08.002
3. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of
cumulative biological risk: MacArthur studies of successful aging. Proc Natl
Acad Sci USA. (2001) 98:4770–5. doi: 10.1073/pnas.081072698
4. McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN,
et al. Mechanisms of stress in the brain. Nat Neurosci. (2015) 18:1353–63.
doi: 10.1038/nn.4086
5. Castanon N, Lasselin J, Capuron L. Neuropsychiatric comorbidity in
obesity: role of inflammatory processes. Front Endocrinol. (2014) 5:74.
doi: 10.3389/fendo.2014.00074
6. Guillemot-Legris O, Muccioli GG. Obesity-induced neuroinflammation:
beyond the hypothalamus. Trends Neurosci. (2017) 40:9–17.
doi: 10.1016/j.tins.2017.02.005
7. Nguyen JCD, Killcross AS, Jenkins TA. Obesity and cognitive decline:
role of inflammation and vascular changes. Front Neurosci. (2014) 8:375.
doi: 10.3389/fnins.2014.00375
8. Foss B, Dyrstad SM. Stress in obesity: cause or consequence?Med Hypotheses.
(2011) 77:7–10. doi: 10.1016/j.mehy.2011.03.011
9. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, et al. Italian
cross-sectional growth charts for height, weight and BMI (2–20 years). J
Endocrinol Invest. (2006) 29:581–93. doi: 10.1007/BF03344156
10. Calcaterra V, Cena H, de Silvestri A, Albertini R, De Amici M, Valenza
M, Pelizzo G. Stress measured by allostatic load in neurologically impaired
children: the importance of nutritional status. Horm Res Paediatr. (2017)
88:224–30. doi: 10.1159/000477906
11. Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress
and impact on health and cognition. Neurosci Biobehav Rev. (2010) 35:2–16.
doi: 10.1016/j.neubiorev.2009.10.002
12. Ganguly P, Alam SF. Role of homocysteine in the development of
cardiovascular disease. Nutr J. (2015) 14:6. doi: 10.1186/1475-2891-14-6
13. Calcaterra V, De Amici M, Leonard MM, De Silvestri A, Pelizzo G, Buttari N,
et al. Serum calprotectin level in children: marker of obesity and its metabolic
complications. Ann Nutr Metab. (2018) 73:177–83. doi: 10.1159/000492579
14. Marshall WA, Tanner JM. Variations in patterns of pubertal changes in boys.
Arch Dis Child. (1969) 45:13–23. doi: 10.1136/adc.45.239.13
15. Marshall WA, Tanner JM. Variations in patterns of pubertal changes in girls.
Arch Dis Child. (1969) 44:291–303. doi: 10.1136/adc.44.235.291
16. McCarthy HD, Jarrett KV, Crawley HF. The development of waist
circumference percentiles in British children aged 5.0–16.9 y. Eur J Clin Nutr.
(2001) 55:902–7. doi: 10.1038/sj.ejcn.1601240
17. Maffeis C, Banzato C, Talamini G, Obesity Study Group of the Italian Society
of Pediatric Endocrinology and Diabetology. Waist-to-height ratio, a useful
index to identify high metabolic risk in overweight children. J Pediatr. (2008)
152:207–13. doi: 10.1016/j.jpeds.2007.09.021
18. National High Blood Pressure Education Program Working Group on High
Blood Pressure in Children and Adolescents. The fourth report on the
diagnosis, evaluation, and treatment of high blood pressure in children and
adolescents. Pediatrics. (2004) 114:555–76. doi: 10.1542/peds.114.2.S2.555
19. d’Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Iafusco D,
et al. Insulin resistance and secretion indexes in healthy Italian children and
adolescents: a multicentre study. Acta Biomed. (2009) 80:21–8.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults. Third report of the National Cholesterol Education
Program Expert Panel on Detection, Evaluation and Treatment of High Blood
Cholesterol in adults (Adult Treatment Panel III). Bethesda: National Heart,
Lung, and Blood Institute (2001).
21. Beckie TM. A systematic review of allostatic load, health, and health
disparities. Biol Res Nurs. (2012) 14:311–46. doi: 10.1177/1099800412455688
22. Lee KH, Park SW, Ye SM, Kim SY, Kim SY, Han JS, et al. Relationships between
dietary habits and allostatic load index in metabolic syndrome patients.
Korean J Fam Med. (2013) 34:334–46. doi: 10.4082/kjfm.2013.34.5.334
23. Calcaterra V, Klersy C, Muratori T, Telli S, Caramagna C, Scaglia F, Cisternino
M, Larizza D. Prevalence of metabolic syndrome (MS) in children and
adolescents with varying degrees of obesity. Clin Endocrinol. (2008) 68:868–
72. doi: 10.1111/j.1365-2265.2007.03115.x
24. Mastorakos G, Ilias I. Interleukin-6: a cytokine and/or a major modulator
of the response to somatic stress. Ann N Y Acad Sci. (2006) 1088:373–81.
doi: 10.1196/annals.1366.021
25. Kelly AS, Metzig AM, Schwarzenberg SJ, Norris AL, Fox CK, Steinberger
J. Hyperleptinemia and hypoadiponectinemia in extreme pediatric obesity.
Metab Syndr Relat Disord. (2012) 10:123–7. doi: 10.1089/met.2011.0086
26. Farr OM, Gavrieli A,Mantzoros CS. Leptin applications in 2015: what have we
learned about leptin and obesity? Curr Opin Endocrinol Diabetes Obes. (2015)
22:353–9. doi: 10.1097/MED.0000000000000184
27. Malendowicz LK, Rucinski M, Belloni AS, Ziolkowska A, Nussdorfer GG.
Leptin and the regulation of the hypothalamic-pituitary-adrenal axis. Int Rev
Cytol. (2007) 263:63–102. doi: 10.1016/S0074-7696(07)63002-2
28. Nye EJ, Bornstein SR, Grice JE, Tauchnitz R, Hockings GI, Strakosch
CR, et al. Interactions between the stimulated hypothalamic-pituitary-
adrenal axis and leptin in humans. J Neuroendocrinol. (2000) 12:141–5.
doi: 10.1046/j.1365-2826.2000.00431.x
29. Van Draanen J, Prelip M, Upchurch DM. Consumption of fast
food, sugar-sweetened beverages, artificially-sweetened beverages and
allostatic load among young adults. Prev Med Rep. (2017) 10:212–17.
doi: 10.1016/j.pmedr.2017.11.004
30. Mattei J, Noel SE, Tucker KL. A meat, processed meat, and French fries
dietary pattern is associated with high allostatic load in Puerto Rican older
adults. J Am Diet Assoc. (2011) 111: 65. 1498–506. doi: 10.1016/j.jada.2011.
07.006
31. Mattei J, Demissie S, Falcon LM, Ordovas JM, Tucker K. Allostatic load is
associated with chronic conditions in the Boston Puerto Rican Health Study.
Soc Sci Med. (2010) 70:1988–96. doi: 10.1016/j.socscimed.2010.02.024
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Calcaterra, Vinci, Casari, Pelizzo, de Silvestri, De Amici, Albertini,
Regalbuto, Montalbano, Larizza and Cena. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Pediatrics | www.frontiersin.org 5 August 2019 | Volume 7 | Article 335
